IAN KINZER: Open Payments
NPI 1043761810 · HUNTSVILLE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,984 in 203 payments from 13 companies in 2025. Trend: 2023 $3,617 · 2024 $2,974 · 2025 $3,984
Food & beverage: $3,867Education: $117
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 40 | $755 |
| Neurocrine BioSciences, Inc. | 28 | $615 |
| Alkermes, Inc. | 28 | $514 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 27 | $424 |
| Otsuka America Pharmaceutical, Inc. | 16 | $420 |
| ABBVIE INC. | 26 | $411 |
| Teva Pharmaceuticals USA, Inc. | 10 | $286 |
| Janssen Pharmaceuticals, Inc | 12 | $232 |
| Lundbeck LLC | 10 | $202 |
| Vanda Pharmaceuticals Inc. | 3 | $73 |
Products named: COBENFY, INGREZZA, ARISTADA, CAPLYTA, VRAYLAR, ABILIFY MAINTENA, REXULTI, INVEGA SUSTENNA.
Industry payments across AL — which companies pay providers there.
